Back to Results
First PageMeta Content
Abdominal pain / Autoimmune diseases / Colitis / Colon / General practice / Alosetron / Ischemic colitis / Megacolon / Ulcerative colitis / Medicine / Health / Gastroenterology


IMPORTANT DRUG WARNING RE: Important New Dispensing Information; Issuance of a Patient Medication Guide  (alosetron hydrochloride) Tablets Safety-related Revisions to Labeling for LOTRONEX Dear Pharmacist:
Add to Reading List

Open Document

File Size: 15,97 KB

Share Result on Facebook

City

Rockville / /

Company

Glaxo Wellcome Inc. / /

/

IndustryTerm

healthcare / /

MedicalCondition

diarrhea-predominant irritable bowel syndrome / toxic megacolon / intestinal obstruction / ulcerative colitis / patients experiencing constipation / hypersensitivity / constipation / non-severe constipation / Crohn’s Disease / severe constipation / ischemic colitis / /

MedicalTreatment

surgery / /

Organization

DOSAGE AND ADMINISTRATION / CONTRAINDICATIONS / Food and Drug Administration / WARNINGS / PRECAUTIONS / /

Person

Richard S. Kent / /

/

Position

Vice President and Chief Medical Officer / Pharmacist / /

Product

LOTRONEX / Patient Medication / /

ProvinceOrState

Maryland / /

PublishedMedium

the Patient Medication Guide / /

URL

www.FDA.gov/medwatch / /

SocialTag